| High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma ET Kimura, MN Nikiforova, Z Zhu, JA Knauf, YE Nikiforov, JA Fagin Cancer research 63 (7), 1454-1457, 2003 | 1931 | 2003 |
| BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas MN Nikiforova, ET Kimura, M Gandhi, PW Biddinger, JA Knauf, F Basolo, ... The Journal of Clinical Endocrinology & Metabolism 88 (11), 5399-5404, 2003 | 1287 | 2003 |
| Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules YE Nikiforov, DL Steward, TM Robinson-Smith, BR Haugen, JP Klopper, ... The Journal of Clinical Endocrinology & Metabolism 94 (6), 2092-2098, 2009 | 837 | 2009 |
| Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas AJ Adeniran, Z Zhu, M Gandhi, DL Steward, JP Fidler, TJ Giordano, ... The American journal of surgical pathology 30 (2), 216-222, 2006 | 643 | 2006 |
| Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer R Ciampi, JA Knauf, R Kerler, M Gandhi, Z Zhu, MN Nikiforova, HM Rabes, ... The Journal of clinical investigation 115 (1), 94-101, 2005 | 575 | 2005 |
| Molecular Profile and Clinical-Pathologic Features of the Follicular Variant of Papillary Thyroid Carcinoma: An Unusually High Prevalence of ras Mutations Z Zhu, M Gandhi, MN Nikiforova, AH Fischer, YE Nikiforov American journal of clinical pathology 120 (1), 71-77, 2003 | 526 | 2003 |
| Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis TJ Giordano, R Kuick, DG Thomas, DE Misek, M Vinco, D Sanders, Z Zhu, ... Oncogene 24 (44), 6646-6656, 2005 | 440 | 2005 |
| Prevalence of RET/PTC Rearrangements in Thyroid Papillary Carcinomas: Effects of the Detection Methods and Genetic Heterogeneity Z Zhu, R Ciampi, MN Nikiforova, M Gandhi, YE Nikiforov The Journal of Clinical Endocrinology & Metabolism 91 (9), 3603-3610, 2006 | 263 | 2006 |
| Delineation, Functional Validation, and Bioinformatic Evaluation of Gene Expression in Thyroid Follicular Carcinomas with the PAX8-PPARG Translocation TJ Giordano, AYM Au, R Kuick, DG Thomas, DR Rhodes, KG Wilhelm Jr, ... Clinical Cancer Research 12 (7), 1983-1993, 2006 | 163 | 2006 |
| Heme oxygenase‐1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury Z Zhu, AT Wilson, MM Mathahs, F Wen, KE Brown, BA Luxon, ... Hepatology 48 (5), 1430-1439, 2008 | 153 | 2008 |
| Dose-Dependent Generation of RET/PTC in Human Thyroid Cells after in Vitro Exposure to γ-Radiation: A Model of Carcinogenic Chromosomal Rearrangement … CM Caudill, Z Zhu, R Ciampi, JR Stringer, YE Nikiforov The Journal of Clinical Endocrinology & Metabolism 90 (4), 2364-2369, 2005 | 144 | 2005 |
| Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase? Z Zhu, AT Wilson, BA Luxon, KE Brown, MM Mathahs, S Bandyopadhyay, ... Hepatology 52 (6), 1897-1905, 2010 | 98 | 2010 |
| Heme and HO-1 inhibition of HCV, HBV, and HIV WN Schmidt, MM Mathahs, Z Zhu Frontiers in pharmacology 3, 129, 2012 | 56 | 2012 |
| BRAF copy number gains in thyroid tumors detected by fluorescence In Situ hybridization R Ciampi, Z Zhu, YE Nikiforov Endocrine pathology 16, 99-105, 2005 | 55 | 2005 |
| Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells Z Zhu, AT Wilson, K Gopalakrishna, KE Brown, BA Luxon, WN Schmidt Journal of medical virology 82 (2), 239-248, 2010 | 40 | 2010 |
| HCV induces telomerase reverse transcriptase, increases its catalytic activity, and promotes caspase degradation in infected human hepatocytes Z Zhu, H Tran, MM Mathahs, TO Moninger, WN Schmidt PloS one 12 (1), e0166853, 2017 | 11 | 2017 |
| Restoration of type I interferon expression by heme and related tetrapyrroles through inhibition of NS3/4A protease Z Zhu, MM Mathahs, WN Schmidt The Journal of infectious diseases 208 (10), 1653-1663, 2013 | 10 | 2013 |
| Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships K Hu, Z Zhu, MM Mathahs, H Tran, J Bommer, CA Testa, WN Schmidt Drug design, development and therapy, 757-771, 2020 | 3 | 2020 |
| BILIVERDIN AND HEME RESTORE TYPE I INTERFERON EXPRESSION IN CELLS EXPRESSING HCV NS3/4A PROTEASE: 365 Z Zhu, MM Mathahs, WN Schmidt Hepatology 54 (4), 541A, 2011 | 2 | 2011 |
| Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity Z Zhu, H Tran, MM Mathahs, BD Fink, JA Albert, TO Moninger, JL Meier, ... Pharmacology research & perspectives 9 (6), e00882, 2021 | 1 | 2021 |
